Novartis

Novartis is a multinational healthcare and pharmaceutical corporation headquartered in Switzerland. Novartis focuses on patented pharmaceuticals, generic medications, and eye care — categories in which they have the requisite innovative capability and global size to compete effectively. At the same time, Novartis is extending its footprint in emerging areas such as Asia, Africa, and Latin America, where the demand for high-quality pharmaceuticals and healthcare is rapidly growing. As of 2019, they employ approximately 103,000 people throughout the world.

Novartis is redefining medicine in order to help people live longer, healthier lives. As a prominent global pharmaceuticals company, it leverages breakthrough science and digital technologies to produce transformative solutions in areas of severe medical need. In their quest to find new treatments, they consistently rank among the world's top firms in terms of research and development investment. Novartis' medicines are used by about 1 billion people throughout the world, and the firm is always seeking for innovative ways to increase access to its newest treatments. Novartis employs more than 125 000 people from more than 140 different countries all over the world.

Novartis is well known for being one of the largest pharmaceutical companies in the world, but it also makes and sells medical technologies. In 2019, the Concept1 inhaler became the first device of any kind to be certified under the new MDR standards of the European Union. (Regulation of Medical Devices)

Founded: December 1996